Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company, their projects – current and future – and the challenges she and her team have to face while developing cell and gene therapy technologies. “We are currently focusing on our cancer vaccine. This … Continue reading Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors